Date | Insider | Price | Amount |
---|---|---|---|
8-18-2020 Insider Buy |
Venrock Healthcare Capital Partners III, L.P. >10% Owner |
$2.52 CAGR » |
$1,137,120.00 451,000 shares |
4-3-2018 Insider Buy |
FMR LLC |
$12.00 CAGR » |
$1,128,624.00 94,052 shares |
4-3-2018 Insider Buy |
Bruce Booth Director |
$12.00 CAGR » |
$1,128,624.00 94,052 shares |
4-3-2018 Insider Buy |
Liam Ratcliffe Director |
$12.00 CAGR » |
$6,600,000.00 550,000 shares |
Also See: Institutional Holders of UMRX
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 08/19/2020 | |
End date: | 10/05/2020 | |
Start price/share: | $3.13 | |
End price/share: | $2.35 | |
Dividends collected/share: | $0.00 | |
Total return: | -24.92% | |
Annualized Gain: | -193.53% | |
Starting investment: | $10,000.00 | |
Ending investment: | $7,508.00 | |
Years: | 0.13 |
UMRX Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent UMRX insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding UMRX
Free UMRX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |